It might be a very minor effect
The World Health Organization now describes obesity as a chronic, relapsing disease and recommends GLP-1 therapies as part of long-term obesity treatment, alongside diet, physical activity and support from health professionals
This means a specific dose is not responsible for a specific side effect
It pressures Pfizer, Roche, and Amgen, all of which are racing to bring obesity drugs to market but now face a dramatically lower price floor and heavy manufacturing costs
At Perfect B, we prescribe BPC-157 to female patients for gut health, post-procedure recovery, and musculoskeletal injuries
Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases